| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis A Rutgers, M Slot, P van Paassen, P van Breda Vriesman, P Heeringa, ... American journal of kidney diseases 46 (2), 253-262, 2005 | 268 | 2005 |
| Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica KSM van der Geest, WH Abdulahad, P Chalan, A Rutgers, G Horst, ... Arthritis & Rheumatology 66 (7), 1927-1938, 2014 | 144 | 2014 |
| Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica KSM van der Geest, WH Abdulahad, A Rutgers, G Horst, J Bijzet, ... Rheumatology 54 (8), 1397-1402, 2015 | 133 | 2015 |
| Different scoring methods of FDG PET/CT in giant cell arteritis: need for standardization MD Stellingwerff, E Brouwer, KJDF Lensen, A Rutgers, S Arends, ... Medicine 94 (37), e1542, 2015 | 131 | 2015 |
| Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS CI van der Made, J Potjewijd, A Hoogstins, HPJ Willems, AJ Kwakernaak, ... Journal of Allergy and Clinical Immunology 149 (1), 432-439. e4, 2022 | 129 | 2022 |
| Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study L Wieske, KPJ van Dam, M Steenhuis, EW Stalman, LYL Kummer, ... The Lancet Rheumatology 4 (5), e338-e350, 2022 | 104 | 2022 |
| Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 92 | 2021 |
| Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy BM Jonkman-Berk, JM Van den Berg, IJM Ten Berge, RGM Bredius, ... Clinical Immunology 156 (2), 154-162, 2015 | 92 | 2015 |
| What is the current evidence for disease subsets in giant cell arteritis? KSM van der Geest, M Sandovici, Y van Sleen, JS Sanders, NA Bos, ... Arthritis & rheumatology 70 (9), 1366-1376, 2018 | 72 | 2018 |
| Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition RRH van den Brom, WH Abdulahad, A Rutgers, BJ Kroesen, ... Rheumatology 55 (6), 1143-1145, 2016 | 72 | 2016 |
| Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission N Lepse, WH Abdulahad, A Rutgers, CGM Kallenberg, CA Stegeman, ... Rheumatology 53 (9), 1683-1692, 2014 | 68 | 2014 |
| The future of damage assessment in vasculitis. P Seo, RA Luqmani, O Flossmann, B Hellmich, K Herlyn, GS Hoffman, ... The Journal of Rheumatology 34 (6), 1357-1371, 2007 | 65 | 2007 |
| High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to α3 (IV) NC1 collagen A Rutgers, KEC Meyers, G Canziani, R Kalluri, J Lin, MP Madaio Kidney international 58 (1), 115-122, 2000 | 64 | 2000 |
| Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies EC O’Brien, WH Abdulahad, A Rutgers, MG Huitema, VP O’Reilly, ... Scientific reports 5 (1), 11888, 2015 | 60 | 2015 |
| Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA) WH Abdulahad, N Lepse, CA Stegeman, MG Huitema, ... Arthritis research & therapy 15, 1-12, 2013 | 57 | 2013 |
| Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides A von Borstel, JS Sanders, A Rutgers, CA Stegeman, P Heeringa, ... Autoimmunity Reviews 17 (4), 413-421, 2018 | 55 | 2018 |
| Breakthrough SARS-CoV-2 infections with the delta (B. 1.617. 2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy … L Boekel, EW Stalman, L Wieske, F Hooijberg, KPJ van Dam, YR Besten, ... The Lancet Rheumatology 4 (6), e417-e429, 2022 | 51 | 2022 |
| ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease A Rutgers, P Heeringa, JG Damoiseaux, JWC Tervaert European Journal of Internal Medicine 14 (5), 287-295, 2003 | 51 | 2003 |
| Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity LPM van Leeuwen, CH GeurtsvanKessel, PM Ellerbroek, GJ de Bree, ... Journal of Allergy and Clinical Immunology 149 (6), 1949-1957, 2022 | 49 | 2022 |
Peter HeeringaProfessor, University of GroningenVerified email at umcg.nl
